Home > Healthcare & Medical Devices > PCR Technologies Market
PCR Technologies Market size was around USD 12 billion in 2022, the industry is anticipated to expand at a CAGR of around 8% by 3032. The polymerase chain reaction is a technique in molecular biology that is used to amplify the DNA segment into billions of copies. It has a wide range of applications including genetic sequencing, cloning, detecting mutations, parenting testing, genetic engineering, and forensic science. The incidence of infectious diseases, genetic disorders & mutations has increased over the last decade, driving the demand for PCR technologies.
PCR has advanced considerably in the field of research & development and significantly influenced genetic sequencing, cloning, and other types of genetic testing. Also, the COVID-19 pandemic has triggered the global revenue for reagents & consumables, instruments, and software.
The PCR technologies market is segmented based on product, techniques, applications, end user, and region.
Based on products, the PCR technologies industry is segmented into reagents & consumables, instruments, software & services, and hyphenated instruments. Among these segments, reagents & consumables comprised the largest portion of the market in 2022. The expanding applications of PCR technologies in clinical disease diagnosis and genetic & molecular research will drive market growth. The industry players have undertaken various strategic initiatives such as long-term contracts for the sale of reagents or bundled sales of consumables.
Based on techniques, the PCR technologies market is segmented into conventional PCR, real-time PCR, digital PCR, reverse transcription PCR, hot-start PCR, and multiplex PCR. In real-time PCR, the accumulation of amplification product is measured as the reaction progresses in real time with product quantification after each cycle. Real-time PCR/qPCR assays have become popular tools for the rapid & sensitive determination and quantitation of nucleic acids in various biological samples with diverse applications such as gene expression analysis, the detection of genetically modified organisms in food, and cancer phenotyping.
Based on end user, the PCR technologies industry is segmented into hospital & diagnostics centers, healthcare industry, research & academic institutes, pharma-biotech companies, applied industries, and other end users. The hospital & diagnostic center industry dominates the global PCR technologies industry. With the increasing prevalence of infectious diseases & genetic disorders, the use of PCR in hospitals and diagnostic centers for disease diagnosis is imperative. The pharmaceutical and biotechnology companies are expected to witness progression during the forecast period with an increasing focus on PCR in research & development activities.
Based on region, North America accounts for the largest share in the global PCR technologies market owing to the increasing demand for technologically-advanced diagnostic tests to detect various genetic disorders, availability of well-advanced healthcare infrastructure, and increased R&D funding in the region.
Higher rates of infectious & chronic diseases, increasing penetration of cutting-edge diagnostic technologies for research & clinical applications, continuous government support for genomic-based research activities, and ongoing expansion of healthcare infrastructure in emerging countries are expected to propel market growth in the Asia Pacific region during the forecast period.
The leading players in PCR Technologies market include Thermo Fisher Scientific Inc, Agilent Technologies Inc, Abbott Laboratories, Eppendrof AG, Sysmex Inostic Inc, Qiagen, Bio-Rad Laboratories Inc, Takara Bio Inc, F. Hoffmann-LA Roche Ltd, Merck KGaA, Fluidigm Corporation, and Promega Corporation.